Most of Haleon's top line was supported by a mixture of price hikes, and to a smaller extent, a better volume and product mix. Combined with the firm's efficiency and productivity initiatives ...

Consumers who bought a popular cough syrup could be eligible for money as part of a class action settlement. Robitussin maker Haleon has agreed to pay $4.5 million to resolve claims it advertised the ...

British consumer healthcare group Haleon on Tuesday said it gained full control of its Chinese joint venture after acquiring ...

GSK’s consumer health spinout Haleon has acquired exclusive US rights to commercialise the gel-based product, called MED3000, in return for an initial upfront payment of $4 million, milestone ...

There’s a strong valuation case for doing so. Haleon to invest $54 mln in US R&D centre to boost product innovation Consumer healthcare company Haleon said on Wednesday it will invest $54 ...

Pfizer PFE has sold off its remaining stake in consumer health company Haleon HLN to institutional investors and Haleon itself for around $3.3 billion. Pfizer sold its 7.3% stake in Haleon ...